sb 203580 has been researched along with inositol 1-phosphate in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (inositol 1-phosphate) | Trials (inositol 1-phosphate) | Recent Studies (post-2010) (inositol 1-phosphate) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 165 | 0 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arzt, E; Gloddek, J; Hopfner, U; Korali, Z; Lohrer, P; Nagashima, AC; Pereda, MP; Renner, U; Stalla, GK | 1 |
1 other study(ies) available for sb 203580 and inositol 1-phosphate
| Article | Year |
|---|---|
Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38alpha mitogen-activated protein kinase/nuclear factor-kappaB pathway.
Topics: Acute-Phase Proteins; Animals; Antibodies; Carrier Proteins; Cell Line; Cells, Cultured; Cyclic AMP; Cycloheximide; Dexamethasone; Glucocorticoids; Imidazoles; Inositol Phosphates; Interleukin-6; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphatidylinositols; Phosphorylation; Pituitary Gland, Anterior; Pyridines; Signal Transduction | 2000 |